Zimmer Biomet CEO on OREF Board | Becker’s Hospital Review
- Ivan Tornos, Zimmer Biomet chairman, president, and CEO, has been appointed to the Orthopaedic Research and Education Foundation (OREF) board.
- Tornos initially joined Zimmer Biomet in 2018 as group president. By 2023, he had risen to president and CEO, later being elected board chair in 2025.
- The move underscores a commitment to accelerate orthopedic research and deliver faster,more effective solutions for patients.
Ivan Tornos, CEO of Zimmer Biomet, is joining the Orthopaedic Research and Education Foundation (OREF) board with a clear mission: to significantly accelerate orthopedic research. This appointment signals a critical step toward faster, more effective solutions for patients. Tornos aims to inject a sense of urgency into the foundation’s work,focusing on advancements in musculoskeletal research and bridging existing gaps in patient care. His leadership will be instrumental in pushing forward innovative orthopedic solutions. Read this story from News Directory 3 to discover how Tornos’s expertise will shape the future of orthopedic advancements. Discover what’s next …
Ivan Tornos Joins OREF Board to Advance Orthopedic Research
Updated May 30, 2025
Ivan Tornos, Zimmer Biomet chairman, president, and CEO, has been appointed to the Orthopaedic Research and Education Foundation (OREF) board. The announcement was made May 29.
Tornos initially joined Zimmer Biomet in 2018 as group president. By 2023, he had risen to president and CEO, later being elected board chair in 2025. His focus now includes driving advancements in musculoskeletal research.
The move underscores a commitment to accelerate orthopedic research and deliver faster,more effective solutions for patients. Tornos’s leadership is expected to bring a sense of urgency to the foundation’s efforts.
“Now more than ever, it’s critically important we move with a sense of urgency and deep purpose to ensure that musculoskeletal research advances at a much faster pace and delivers even bolder solutions,” Tornos said. “Ther are countless patients currently waiting on the sidelines who could benefit from the meaningful work that we will do together, and I’m committed to doing all I can to reduce the current gaps in this area.”
What’s next
With Tornos on board, OREF anticipates a renewed push for innovative orthopedic solutions, aiming to bridge existing gaps and improve patient outcomes in musculoskeletal health.